Cramer Pamela J. bought RYTM
December 11, 2025 · Form 4 insider transaction
Cramer Pamela J. bought 3,350 shares of Rhythm Pharmaceuticals, Inc. at $27.35 per share, a transaction worth $91.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,350
Price
$27.35
Total value
$91.6K
InsiderCramer Pamela J.
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 11, 2025
Filing dateDecember 15, 2025
Shares owned after24,164
OwnershipDirect
10b5-1 planNo
AmendedNo